These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 14583643)

  • 1. Evaluation of simian immunodeficiency virus-specific immune responses induced by a defective proviral DNA vaccine in macaques.
    Takeda A; Nakamura H; Matano T
    Jpn J Infect Dis; 2003 Aug; 56(4):172-3. PubMed ID: 14583643
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of virus-specific T cell responses by dendritic cell vaccination in the chronic phase of simian AIDS models.
    Kato M; Igarashi H; Takeda A; Horie S; Higashihara E; Matano T
    Jpn J Infect Dis; 2004 Oct; 57(5):220-3. PubMed ID: 15507782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
    Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
    Chong SY; Egan MA; Kutzler MA; Megati S; Masood A; Roopchard V; Garcia-Hand D; Montefiori DC; Quiroz J; Rosati M; Schadeck EB; Boyer JD; Pavlakis GN; Weiner DB; Sidhu M; Eldridge JH; Israel ZR
    Vaccine; 2007 Jun; 25(26):4967-82. PubMed ID: 17335943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of peak viremia by an integration-defective SIV proviral DNA vaccine in rhesus macaques.
    Wang C; Gao N; Song Y; Duan S; Wang W; Cong Z; Qin C; Jiang C; Yu X; Gao F
    Microbiol Immunol; 2020 Jan; 64(1):52-62. PubMed ID: 31544982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of SIV-lipopeptide immunizations administered by the intradermal route in their ability to induce antigen specific T-cell responses in rhesus macaques.
    Coutsinos Z; Villefroy P; Gras-Masse H; Guillet JG; Bourgault-Villada I
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):357-66. PubMed ID: 15708309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.
    Kawada M; Igarashi H; Takeda A; Tsukamoto T; Yamamoto H; Dohki S; Takiguchi M; Matano T
    J Virol; 2006 Feb; 80(4):1949-58. PubMed ID: 16439550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a DNA prime and recombinant adenovirus boost regime significantly varies between rhesus macaques of Chinese and Indian origins.
    Stahl-Hennig C; Suh YS; Park KS; Sauermann U; Kim KS; Ahn S; Franz M; Schulte R; Stolte-Leeb N; Hunsmann G; Sung YC
    J Med Primatol; 2007 Aug; 36(4-5):195-205. PubMed ID: 17669208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and induction of immune responses by a DNA AIDS vaccine.
    Smith JM; Leung NJ; Torres JV
    Viral Immunol; 2000; 13(3):343-51. PubMed ID: 11016598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques.
    Boyer JD; Robinson TM; Kutzler MA; Parkinson R; Calarota SA; Sidhu MK; Muthumani K; Lewis M; Pavlakis G; Felber B; Weiner D
    J Med Primatol; 2005 Oct; 34(5-6):262-70. PubMed ID: 16128921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques.
    Amara RR; Ibegbu C; Villinger F; Montefiori DC; Sharma S; Nigam P; Xu Y; McClure HM; Robinson HL
    Virology; 2005 Dec; 343(2):246-55. PubMed ID: 16185742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles.
    Puaux AL; Marsac D; Prost S; Singh MK; Earl P; Moss B; Le Grand R; Riviere Y; Michel ML
    Vaccine; 2004 Sep; 22(27-28):3535-45. PubMed ID: 15315833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.
    Malkevitch NV; Patterson LJ; Aldrich MK; Wu Y; Venzon D; Florese RH; Kalyanaraman VS; Pal R; Lee EM; Zhao J; Cristillo A; Robert-Guroff M
    Virology; 2006 Sep; 353(1):83-98. PubMed ID: 16814356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.